Key facts
- It has raised $319.8M; the latest was PE Growth/Expansion in Aug 2025.
- Notable investors include Investindustrial, Ardian France, Doppel Farmaceutici.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ourvita
- ·The full record, as it builds
Funding rounds
No funding rounds for Ourvita are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ourvita
Provider of outsourced contract development and manufacturing services intended to serve pharmaceutical companies. The company's offerings include the development, production and packaging of food supplements, medical devices and cosmetics, enabling clients to get access to regulatory support, clinical trial services, and stability studies.
- Sector
- Business Products and Services (B2B)
- HQ
- Bergamo, Italy
- Founded
- 1939
- Employees
- 3,000
- Website
- ourvita.com/
- Ownership
- Privately Held (backing)
Ourvita doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ourvita shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ourvita in its N-PORT filings yet. We sweep new filings monthly.